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Summary 
Translocation-associated Notch homologue (TAN-l), a gene originally cloned from the trans- 
location breakpoint of a human T  cell leukemia carrying a 9:7(q34.3) translocation, encodes a 
protein belonging to the Notch/Lin-12/Glp-1 receptor family. These receptors mediate the 
specification of numerous cell fates during development in invertebrates and vertebrates. The 
intracellular portion of Notch/TAN-1 contains six ankyrin repeats that are similar to those found 
in cytoplasmic Ir  proteins. IKB proteins are specific inhibitors of nuclear factor (NF)-cd3/Rel 
transcription factors. Here we show that TAN-1 has functional properties of an Icd3-1ike regu- 
lator with specificity for the NF-ed3 p50 subunit. A recombinant polypeptide corresponding to the 
cytoplasmic portion of  TAN-1 (TAN-lc) specifically inhibited the DNA binding ofp50-contain- 
ing NF-KB complexes. When overexpressed in an appropriate cell line, TAN-1 c  prevented 
KB-dependent transactivation in transient reporter gene assays in a fashion similar  to the struc- 
turally related protein, Bcl-3. TAN-1 c could activate KB-dependent gene expression by atten- 
uating the inhibitory effect of an excess of  p50 hom,odimers. Immunoprecipitation experiments 
showed that the TAN-1 from a T  cell hne is associated with NF-KB containing p50 and p65 
subunits.  These observations indicate that TAN-1 c  may directly engage NF-Id3 transcription 
factors and modulate nuclear gene expression. 
T 
he Notch/Lin-12 family of transmembrane receptors 
is beheved to play a pivotal role in  development by 
regulating cell-fate decisions (1-5). Extensive genetic stud- 
ies of the Notch locus in invertebrates have revealed its roles 
during embryonic development of eyes, bristles,  central and 
peripheral nervous system, muscles, and wings (6, 7). These 
observations have led to the hypothesis that Notch may not 
directly specify cell fate but rather inhibits specific signals 
required for cell-type specification. Translocation-associated 
Notch  homologue  (TAN-l) 1,  the  human  counterpart  of 
the Drosophila  Notch, was discovered as a t(7;9) (q34.3) re- 
ciprocal  translocation  in  the  TCR-[3  locus  in  certain  T 
lymphocytic leukemias  (8).  Altered  expression  of Notch 
proteins is also associated with cell fate abnormalities such as 
cervical and other epithelial neoplasias (9). 
TAN-1  is expressed in a broad range of human  tissues 
and is relatively highly expressed in lymphoid organs and 
I  Abbreviations used in this paper: EMSA, electrophoretic  mobility  shift  assay; 
GST, glutathione-S-transferase; NF,  nuclear factor; OTF1, octamer- 
binding transcription factor 1;  TAN-l,  translocation-associated Notch 
homologue; TAN-lc, cytoplasmic  portion of TAN-1. 
the central nervous system. TAN-1 consists  of an extracel- 
lular region containing 36 epidermal growth factor (EGF)- 
like segments, 3 Notch/Lin-12 repeats, and an intracellular 
portion containing 6 tandemly arranged ankyrin repeats, in 
addition to other functional domains (8). The extracellular 
portion of Notch proteins is thought to mediate receptor- 
ligand  interactions  (10,  11).  The intracellular ankyrin re- 
peats of Notch may be involved in protein-protein interac- 
tions that mediate transmission of the Notch signal  to the 
nucleus (12-14). 
Nuclear Factor (NF)-KI3/I:kel  transcription factors are in- 
volved in the inducible expression of many genes contain- 
ing  cis-acting  KB-binding motifs,  including  certain  genes 
with important functions in immune, inflammatory, and acute 
phase responses (15,  16).  In higher vertebrates, the DNA- 
binding subunits  of NF-KB/Rel proteins encompass p50, 
p65 (R.elA), c-Rel, p52, and P,  elB (17-22). These can to a 
limited extent homo- and heterodimerize, resulting in com- 
plexes with distinct DNA-binding specificity (23-26). Mul- 
tiple stimuli cause a translocation of cytosolic NF-cd3/P,.el 
factors to the nucleus where they transactivate KB-depen- 
dent genes. This process is controlled by a class of inhibi- 
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Rel  factors  in  the  cytoplasm  and  suppress  their  DNA- 
binding  activity  (26-28).  These  include  IKB-o~,  IKB-[3, 
Bcl-3,  and  the  NF-r  precursor proteins pl00  and  p105 
(29-35).  Upon  activation,  IKB  proteins  undergo  a  pho- 
phorylation-controlled proteolysis that allows the released 
NF-KB/ILel factor  to  enter  the  nucleus  and  transactivate 
genes  (24,  36-38).  A  common  structural  feature  of IKB 
proteins  is  the  presence  of five  to  seven  closely adjacent 
ankyrin repeats. Mutational analysis has shown that each of 
these repeats is required for the functional integrity of the 
proteins (32, 39). 
Bcl-3 is an exceptional IKB protein. While it inhibits the 
DNA  binding  of transcriptionally inactive p50  dimers,  it 
can  also  associate with  p52  dimers  on  DNA  and  provide 
the NF-KB/1Lel protein with transactivating potential (30, 
31, 33, 34, 40). Like TAN-l,  Bcl-3 was identified as a gene 
aberrantly expressed as a consequence  of a translocation in 
leukemic cells (41). The structural similarity between the cy- 
toplasmic  portion  of  TAN-1  and  various  IKB  proteins 
prompted us to investigate the potential of TAN-1 to func- 
tion as a membrane-bound and, eventually, cytoplasmically 
released form of IKB. Here we report that the cytoplasmic 
portion of TAN-1 (TAN-lc) is a specific inhibitor of NF-~B 
complexes containing the p50 subunit. In cells overexpress- 
ing TAN-l, endogenous NF-KB is found associated with the 
receptor.  We  infer that  the  TAN-1  receptor can  regulate 
nuclear gene expression by directly interacting with mem- 
bers of the NF-v,B transcription factor family. 
Materials  and Methods 
Purification of Glutathione-S-transferase--TAN- 1 Fusion Protein and Anti- 
body Production.  The  expression  construct  for  gluthatione-S-trans- 
ferase (GST)-TAN-1  contained a  coding sequence  from amino 
acids 1774 to 2230  cloned into the pGEXlkT vector (Pharmacia, 
Uppsala, Sweden). Control protein, GST, was prepared from cells 
containing unmodified pGEXIKT  vector.  GST-TAN-1  fusion 
protein and GST were expressed in BL21(DE3)  (Novagen, Inc., 
Madison, WI).  Soluble protein extracts were prepared by mild 
sonication. Cell debris were removed by centrifugation. The su- 
pernatant was  loaded onto a Sepharose-glutathione affinity col- 
umn, washed with solution A, 0.5% Triton X-100 in 0.5 M NaC1 
and 10 mM Tris, and solution B, 50 mM Tris, pH 8.0, and then 
eluted with 10 mM glutathione in 50 mM Tris, pH 8.0. The ap- 
parent molecular mass  of GST-TAN-1  fusion protein  (78  kD) 
was determined by 10% SDS-PAGE. An identical procedure was 
used for purification of GST. GST-TAN-1 and GST protein con- 
centrations were determined with a protein assay reagent  (Bio- 
R.ad  Laboratories, ILichmond,  CA),  according to the manufac- 
turer's protocols. This purified GST-TAN-1  fusion protein was 
used to immunize rabbits for antibody production. 
Electrophoretic Mobility Shift Assay.  Jurkat  T  cells  were  cul- 
tured in ILPMI-1640 supplemented with  10%  FCS and treated 
with 50 ng/ml PMA (Sigma, Chemical Co., St. Louis, MO) for 
3 h. Nuclear extracts were prepared as described elsewhere (42). 
Briefly, pelleted cells were suspended in 5 vol of cold PBS and 
collected by centrifugation at 4~  The cells were suspended in 
5 vol packed cell pellet of buffer A containing 10 mM Hepes (pH 
7.9),  1.5  mM MgC12, 10  mM KC1,  and 0.5  mM  dithiothreitol 
(DTT). The cells were allowed to stand for 10 min and were then 
centrifuged for  10  rain at 2,000  rpm in a  rotor (model HG4L; 
Sorval, Newtown, CT). 2 vol of buffer A was added to the pellet. 
The cells were lysed by a glass homogenizer (Kontes Co., Vine- 
land, NJ). The homogenate was centrifuged at 2,000 rpm to pellet 
nuclei. The nuclear pellet was subjected to a second centrifugation 
at 25,000 g for 20 vain.  The pellet was resuspended in 3  ml of 
buffer C  (20  mM  Hepes, pH 7.9,  25%  glycerol, 0.42 M  NaCl, 
1.5 mM MgCI2, 0.2 mM EDTA, 0.5  mM PMSF, and 0.5  mM 
DTT)  per 109 cells and lysed with a Kontes glass homogenizer. 
The resulting suspension was centrifuged at 25,000 g for 20 rain. 
The supernatant was frozen at -80~  DNA-protein-binding re- 
actions were carried out in 10 mM Tris, pH 7.5,  10 mM EDTA, 
0.5 mM DTT, 50 mM NaC1, 2/~g poly(dI-dC) (Pharmacia), and 
5% glycerol in a final vol of 20 ~1. The reaction contained 6 p,g of 
nuclear extract and five-end-labeled Ig enhancer binding probes. 
GST-TAN-1 or GST was added directly to the binding reaction. 
The reaction was kept at room temperature for 30 rain and loaded 
on  a  nondenaturing  6%  polyacrylamide gel  using  0.5 X  Tris/ 
Borate/EDTA buffer for 3 h  at  150 V.  P50 and p65  antibodies 
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). 
Expression Constructs and In  Vitro Translation.  The TAN-1 con- 
struct contains the sequence of the TAN-1  intracellular portion 
including amino acids 1774  to 2230,  which is identical to the 
sequence of GST-TAN-1 fusion protein. P50 and p65 constructs 
have been described elsewhere (22). The expression of p50, p65, 
TAN-l, and Bcl-3 was directed by the expression vector ILc CMV 
(Invitrogen, San Diego, CA). The Bcl-3 construct was a kind gift 
of Dr. I.M. Verma (Salk Institute, San Diego, CA). The reporter 
plasmids contain a luciferase gene driven by the six reiterated KB 
sites. Translation of full-length p50 and p65 was performed in the 
presence or absence of r-[3SS]methionine using wheat germ ex- 
tracts  according  to  manufacturer's  protocols  (Promega,  Corp., 
Madison, WI). Translated products were analyzed by SDS-PAGE 
(10%) followed by autoradiography. 
Cell Culture and Transient Transfection Experiments.  NTera-2  cells 
(American Type  Culture  Collection  [ATCC],  ILockville, MD) 
were grown in DMEM containing 10% FCS. NTera-2 cells were 
transfected with expression vectors in a 6-well plate in the pres- 
ence of lipofectamine (GIBCO  BILL,  Gaithersburg, MD).  The 
transfection was pertbnned according to the manufacturer's stan- 
dard protocols. After 48 h,  the cells were harvested and extracts 
assayed for luciferase activity using a kit (Promega Corp.) accord- 
ing to the manufacturer's instructions. 
Immunoprecipitation and Western Blot Analysis.  Sup-T1 cells (from 
Dr. J.  Hoxie)  and  U266  cells (ATCC)  were  extracted in  1% 
Triton X-100 (Sigma Chemical Co.), 50 mM Tris, pH 7.5,  1 mM 
PMSF, 1 ~g/ml leupeptin, 1 ~g/ml pepstatin, 1 p~g/ml E64, and 
40 p~g bestatin (Boehringer Mannheim, Mannheim, Germany) at 10 s 
cells/ml for 1 h on ice. Soluble detergent extracts were incubated 
with p50 or p65 antibodies (Santa Cruz Biotecbnology) for 2 h at 
room temperature and then at 4~  overnight after the addition of 
protein G-Sepharose beads.  The  beads were washed five times 
with 140 mM NaC1, 10 mM Tris, pH 7.5, and 0.5% Triton X-100, 
and were then boiled in SDS sample loading buffer under reduc- 
ing conditions for 10 rain, and run on a 4-20% SDS-PAGE, fol- 
lowed by electrotransferring to polyvinylidene difluoride mem- 
branes. Membranes were blocked with 5% BSA in TBS for 2 h, 
and then sequentially incubated with rabbit anti-TAN-1 antibody 
or preimmune IgG, followed by alkaline phosphatase-conjugated 
anti-rabbit IgG heavy and light chains  (Bio-ILad Laboratories). 
Alkaline phosphatase substrate was detected by Lumi-Phos  TM 530 
(Boehringer Mannheim). 
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TAN-1 c Is a Specific Inhibitor of NF-KB.  The  mechanism 
by which proteins in the Notch family function is incom- 
pletely understood. A  recent study showed that a construct 
consisting primarily of six ankyrin repeats ofgermline prolif- 
eration-i, a member of the Notch family, is sufficient to con- 
trol downstream regulators of cell fate in  Caenorhabditus  ele- 
gans  (12).  Another  report  (14)  showed  that  a  cytoplasmic 
protein,  Deltex,  positively  regulates  the  Notch  pathway 
through interactions with the Notch ankyrin repeats. A  GST 
fusion protein,  corresponding to  the  Notch/TAN-1  intra- 
cellular domain  containing  six ankyrin  repeats  and  NH z- 
and COOH-terminal flanking sequences of TAN-1  (amino 
acids 1774-2230),  was produced in Escherichia coli and puri- 
fied by  affinity chromatography.  GST  was  also  expressed 
for use as a control and purified in the same way. Both pro- 
teins were examined for inhibition of NF-KB DNA  bind- 
ing to  a  consensus  KB  site.  In an  electrophoretic mobility 
shift  assay  (EMSA)  with  nuclear  extracts  from Jurkat  T 
cells, TAN-lc  inhibited DNA binding of NF-KB that had 
been  activated by treatment  of cells with PMA  (Fig.  1 A, 
lane 5; Fig. 1 B, lanes 2-4). Treatment of DNA-binding re- 
actions  with  specific  antibodies  showed  that  the  NF-KB 
complex  contained  both  p50  and  p65  subunits  (Fig.  1  B, 
lanes  6  and  7).  The  activity of GST-TAN-1 c  was specific 
since it did not affect the activity of endogenous octamer- 
binding transcription factor  1  (OTF1)  (Fig.  1  C)  and  the 
GST portion alone showed  no inhibitory effect in EMSA 
(Fig. 1 A, lane 6; Fig. 1 B, lane 5). For complete inhibition 
of the  NF-KB  complex,  4  pmol of GST-TAN-1  was  re- 
quired,  which  is  comparable  to  the  amount  of IKB-ci  or 
Bcl-3 necessary for inhibition of NF-KB (29, 30). 
NF-KB Subunit  Specificity  of TAN-I c.  Using  in  vitro- 
translated p50  or p65,  we tested whether the  IKB-like ac- 
tivity of GST-TAN-1 c  was  specific for  NF-KB  subunits. 
GST-TAN-1 c  effectively inhibited DNA  binding  of p50 
dimers but not that of p65 dimers (compare Fig. 2 A, lanes 
3  and  4).  The  inhibition of p50  dimer DNA  binding by 
GST-TAN-lc  was  concentration  dependent  (Fig.  2  B). 
This  subunit  specificity resembles that  of the  protoonco- 
gene, Bcl-3,  and is different from those  of IvA3-oL and -[3, 
which  selectively interact with p65  (29,  30,  33).  Interest- 
ingly, the  ankyrin repeats of TAN-1  are more  closely re- 
lated to Bcl-3 (50% similarity and 29% identity) than IKB-oL 
(45% similarity and 22% identity). These results suggest that 
NF-KB dimers containing the p50  subunit are a  target for 
negative regulation by human Notch/TAN-1  molecules. 
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Figure 1.  Specificity  of  inhibition of 
DNA binding  of nuclear NF-KB by 
recombinant  TAN-1  c.  (A)  PMA- 
induced nuclear extracts were assayed 
with  bacterially  expressed GST- 
TAN-1  c or control protein, GST, in 
an  EMSA  using  radiolabeled  Kt3 
DNA. Lane  1,  [32p]-KB DNA probe 
alone; lane  2,  nuclear  extracts (NE) 
with probe; lane 3, specific competi- 
tor (SC) (KB DNA); lane 4, nonspe- 
cific competitor  (NSC)  (Sp-1 DNA); 
lane 5, TAN-1 (4 pmol); and lane 6, 
GST  (4 pmol).  The  faster migrating 
band is considered a nonspecific bind- 
ing component  that  may  cross-react 
with  KB DNA present in the nuclear 
extracts, as this complex does not su- 
pershift in the presence of anti-p50 or 
anti-p65 antibodies (data not shown). 
(B)  The  same nuclear  extracts were 
analyzed in an EMSA including in the 
presence of anti-p65 and p50 antibod- 
ies. Lanes 1-4,  TAN-1  (0,  1,  2,  and 
4 pmol); lane 5,  GST  (4 pmol); and 
lanes 6 and 7, p50 and p65 antibodies, 
respectively. (Bracket) Positions of im- 
mune  complexes. (C)  The same nu- 
clear  extracts were  analyzed in  an 
EMSA with radiolabeled  KB and OTF1 
probes.  Lane  1,  nuclear  extract plus 
GST (4 pmol) and OTF1  probe; lane 
2, nuclear extract plus TAN-1 (4 pmol) 
and OTF1  probe; lane 3, nuclear ex- 
tracts  plus  GST  (4  pmol)  and  KB 
probe; and lane 4, nuclear extract plus 
TAN-1  (4 pmol) and KB probe. The 
positions of NF-KB and OTF1 are in- 
dicated. Figure 3.  Association of TAN-1  with  p50. (A)  Translated product 
(5 ~1) was analyzed  by SDS-PAGE  on a 10% gel, followed  by autoradiog- 
raphy. Lane 1, p65; lane 2, p50. (B) 3sS-labeled in vitro-translated p50 
(10 Ixl) or p65 (10 I~1) was incubated with  10 ~g of GST-TAN-1 c or 
10 lag of GST bound to Sepharose-glutathione beads. The reaction mix- 
ture was rotated at 4~  for 4 h, and subsequently washed and e|uted. The 
eluted samples were run on a 10% SDS-PAGE,  followed  by autoradiogra- 
phy. Lane 1, p50 plus GST; lane 2, p65 plus GST; lane 3, p50 plus GST- 
TAN-lc; lane 4, p65 plus GST-TAN-1  c. 
Figure 2.  Subunit  specificity of the inhibition of r,B DNA-binding ac- 
tivity by GST-TAN-lc.  (A) 1kadiolabeled KB probe was incubated with: in 
vitro-transhted p50 (1 ~1), lane 1; p65 (4 lal), lane 2; 1 gl of  p50 plus GST- 
TAN-1  (4 pmol), lane 3; and 4 ~1 of p65 plus GST-TAN-1  (4 pmol), 
lane 4. (B) I Ixl of p50 was incubated with TAN-1 (0, 0.3, 0.6, 1, 2, and 
4 pmol), lanes I-6. 
Direct Binding of TAN-1  to NF-KB p50 Subunit.  We did 
not observe GST-TAN-lc  directly binding to the  gB site 
on DNA (data not shown). Therefore, it may prevent DNA 
binding  of p50-containing  NF-KB  complexes  by binding 
to the p50 subunit.  To demonstrate such a direct protein- 
protein interaction, GST-TAN-1  c was tested for precipitation 
of in vitro-translated p50 and p65 on glutathione Sepharose 
beads.  In vitro-translated 3SS-labeled p50 and p65 products 
are  shown in Fig.  3  A, lanes  1 and 2.  GST-TAN-1 c  pre- 
cipitated  p50  but  not p65  (Fig.  3  B,  lanes  3  and  4).  The 
GST  control precipitated  neither  p50  nor p65  (Fig.  3  B, 
lanes  1 and 2),  indicating that the inhibition  of the DNA- 
binding activity of p50 is specific and dependent on a direct 
association between p50 and TAN-1. These results suggest 
that TAN-1 functions as a bona fide IKB protein. 
TAN-1 c  Can  Modulate  NF-KB-Dependent  Transactiva- 
tion.  We further investigated the effect of overexpressing 
the cytoplasmic domain of TAN-1 on rd3-dependent trans- 
activation  in  intact  cells.  In NTera-2  cells,  the  high  level 
expression  of a  chloramphenicol  acetyl  transferase  (CAT) 
gene  driven by the  KB sites  of the  HIV-KB-LT1K or of a 
luciferase  gene  driven by six  reiterated  KB  sites  is  depen- 
dent  on  cotransfection  of NTera-2  cells  with  expression 
vectors for NF-KB proteins (31, 33, 40). As shown in Fig. 4 A, 
coexpression of TAN-lc or Bcl-3 decreased the gB-depen- 
dent transactivation of the luciferase reporter gene in a dose- 
dependent manner (Fig. 4 A). In this experiment,  the ratio 
of p50  to  p65  plasmids  was  1:1.  Similar  results  were  ob- 
tained  with  a  HIV-KB-LT1k-driven CAT  gene  (data  not 
shown).  In the presence of increased concentrations of p50 
expression vector (p50/p65 plasmid ratio  =  6:1), a bimodal 
effect of TAN-1 c  was  observed  (Fig.  4  B).  Whereas  high 
concentrations of TAN-1 c  vector resulted in an inhibition 
of transactivation as seen in Fig. 4 A, lower concentrations 
of  transfected  TAN-1 c  vector  resulted  in  an  increased 
transactivation  (Fig.  4  B).  This  behavior resembles  that  of 
Bcl-3  (compare  Fig.  4  B,  right).  TAN-l,  like  Bcl-3,  ap- 
peared  to  be  able  to  reverse  the  transcriptional  inhibition 
imposed by high amounts  of p50  dimers.  Higher levels  of 
TAN-1  expression  may  also  interfere  with  p50/p65  het- 
erodimers resulting in a net inhibition of reporter gene ex- 
pression. These data indicate that TAN-1 c has the potential 
to facilitate  NF-KB-dependent  gene  expression which has 
been shown to be an important step in T  cell activation (43). 
Sup-T1  T  Cells  Contain  a  NF-KB-TAN-1  Complex. 
The  preceding  experiments  suggested  a  direct  and  func- 
tional interaction  of TAN-lc  with NF-KB in vitro and in 
vivo. We therefore sought evidence for a physical associa- 
tion  between  TAN-1  and  p50  containing  NF-KB  com- 
plexes under physiologic conditions. We analyzed anti-p50 
and  anti-p65  immunoprecipitates  from  Sup-T1,  a  T  cell 
line that contains copies of both the normal and truncated 
TAN-1  gene and U266,  a mature B  cell line  (plasma cell) 
that  does  not  express  detectable  levels  of Notch  protein. 
Preimmune  IgG did not detect  TAN-1  in  either  cell line 
(Fig. 5, lanes  1 and 2) and anti-TAN-1  antibody found no 
evidence  of TAN-l-related  peptides  in  the  U266  control 
(Fig. 5, lane 3). However, anti-TAN-1  antibody did reveal 
the presence  of two peptides  in anti-NF-KB  immunopre- 
cipitates  from  Sup-T1  cell  line  cells.  The  90-kD  species 
observed is consistent with the truncated protein predicted 
from the  sequence  resulting  from  the  chromosomal  rear- 
rangement seen in this cell line and certain T  cell leukemias 
(8).  The less abundant  100-kD species likely corresponds to 
a proteolytic product of human Notch, in that a peptide of 
identical  molecular weight  has been  consistently  observed 
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TAN-1 modulates transactivation mediated by NF-KB. (A) Transactivation of 6 KB-luciferase  reporter  (0.3 p.g) plasmids by transfection of 
NTera-2 cells with expression vectors encoding columns:  I, reporter plasmids; 2, vectors as used in 1 plus p65 (0.5 p.g) and p50 (0.5 p.g); 3-7, vectors as 
used in 2 plus increasing amounts of TAN-1 or Bcl-3 vector 0.1, 0.3,0.5, 1, and 2 p.g. (B) Column 1, reporter plasmid (0.3 p.g); 2, vectors as 1 plus p65 
(0.05 p~g) and p50 (3 p.g); 3-7, vectors as 2 plus increasing amounts of TAN-1 or Bcl-3 vector 0.1, 0.3, 0.5, 1, and 3 Ixg. 
in  a  variety  of human  cell  extracts,  including neuroblas- 
toma NB5 cells (9,  11). 
These  data  suggest  that  membrane-associated  Notch 
(TAN-l)  may  prevent  nuclear  localization  of NF-KB  in 
human T  cells as has been proposed  for Drosophila nuclear 
transcription factors (44). 
Figure 5.  TAN-1 interacts with NF-KB. U266 or Sup-T1 T cells were 
lysed and immunoprecipitated  with anti-pS0 or anti-p65 antibodies. The 
immunoprecipitates were analyzed by SDS-PAGE (4-20%) and transferred 
to PVDF membranes. Lanes 1 and 2, U266 or Sup-T1 T immunoprecip- 
itates were probed with preimmune rabbit IgG that did not detect TAN-1 
bands. Lanes 3-5, U266 or Sup-T1 immunoprecipitates were probed with 
TAN-1 antibody that detected TAN-1 bands from Sup-T T cells but not 
from  control  cells, U266.  Bands corresponding  to IgG heavy and light 
chains from pS0 and p65 antibodies that reacted with detection  system, 
alkaline phosphatase-labeled anti-rabbit lgG (H+L) are also indicated. 
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Discussion 
In this  paper  we  show  that  the  intracellular domain of 
Notch/TAN-1  specifically  inhibits  NF-KB  activity  and 
binds p50 in vitro.  Its transfection modulates KB-mediated 
transactivation.  TAN-1  related  peptides,  including  that 
predicted from the translocation event, are found associated 
with NF-KB in a leukemic T  cell line. 
The  intracellular events that follow Notch-ligand inter- 
actions are, however, unclear. In Drosophila, recent data sug- 
gest that Notch signaling controls nuclear events that influ- 
ence the progression of uncommitted cells to a more highly 
differentiated state. Three loci encoding putative nuclear pro- 
teins, Drosophila Su (H) (homolog of mammalian C  promoter 
binding factor), Enhancer of split, and Mastermind, have been 
implicated in these nuclear events (14, 45--47). Several recent 
studies  have  shown  that  the  ankyrin repeats  of the  intra- 
cellular portion  of Notch  associate  with  cytoplasmic  pro- 
teins. For example, Drosophila Notch-derived ankyrin repeat- 
containing peptides have been shown to bind the cytoplasmic 
protein,  Deltex.  Mouse  Notch  ankyrin  repeats  associate 
with the human analogue of Su(H),  KBF2/CBF-1, and act as  transcriptional  activators through the  r,  BF2-bindmg sites 
of the mouse Hairy enhancer of split  1 promoter  (48).  Inter- 
estingly,  the  Deltex-Notch  interaction  prevents  the  ob- 
served  cytoplasmic retention  of the  suppressor  of Hairless 
protein by Notch ankyrin repeats resulting in nuclear trans- 
location (44). These observations highlight the significance 
of our findings in the  context of a mechanism relevant to 
the human system in which Notch is thought to play a po- 
tentially pathogemc role. 
Adjacent  ankyrin  repeats  have  been  shown  to  mediate 
protein-protein  interactions  (30,  32,  49,  50).  Mutations 
disrupting single ankyrin repeats  in Bcl-3,  pp40,  and p105 
rendered these proteins incapable of suppressing the DNA- 
binding activity of NF-KB or associating with NF-KB/ILel 
proteins.  This  demonstrates  that  ankyrin motifs  are  abso- 
lutely required  for the functional interaction between  IKB 
and NF-KB  (30,  32).  So far the ankyrin repeats  of human 
Notch have not been demonstrated to associate with intra- 
cellular  proteins.  Our  data  suggest  that  members  of the 
well-characterized  NF-KB/R.el  transcription  factor family 
serve,  under  physiologic  conditions,  as  signal  transducers 
for  Notchl/TAN-1  receptors.  The  structural  and  patho- 
physiological analogy between the TAN-1  and Bcl-3 pro- 
tooncogene is  now further extended  by a functional rela- 
tionship:  both  proteins  specifically  bind  the  p50  NF-KB 
subunit and show similar effects on KB-dependent transac- 
tivation.  The  Bcl-3  protooncogene  that  shows  increased 
expression in chronic lymphocytic leukemia  cells contain- 
ing  the  translocation  t(14;19)  (q32;q13.1),  differs  from 
TAN-1  in  that  it  lacks  a  transmembrane  domain,  and  is 
predominantly nuclear. However, earlier studies indicate that 
truncated,  putatively  activated  forms  of Notch  without 
transmembrane  and  extracellular  domains  are  translocated 
to  the  nucleus in transgenic  flies  and in transfected  mam- 
malian or Drosophila  cells  (13,  14, 47,  51).  Sequence com- 
parison  and  deletion  analysis  have  identified  two  nuclear 
localization  sequences  that  reside  on  either  side  of the 
Notch ankyrin repeats.  Preliminary data indicate that trun- 
cated  human  Notch/TAN-1  is  present  in  both  the  cyto- 
plasm  and  nucleus  (Guan,  E.,  unpublished  observations). 
These findings raise  the possibility that the  oncogenic and 
possibly physiologically activated forms of TAN-1 are trun- 
cated and, like Bcl-3, may act in the nucleus. Another Notch- 
related  protein  that may fall  into  a  novel class  of proteins 
with ankyrin repeats and a functional association with con- 
trol of normal and neoplastic cell proliferation is the mouse 
mammary tumor  gene  product,  int-3  (52).  However,  the 
mechanism(s) by which TAN-1 could contribute to malig- 
nancy has remained elusive.  The family of Rel-related and 
ankyrin motif-containing proteins has been associated with 
tumorigenesis,  v-P,.el-containing  viruses  are  highly  trans- 
forming; c-R.el, p50B, Bcl-3, and TAN-1 are located at sites 
of recurrent translocations and genomic rearrangements  (8, 
40,  41,  53,  54).  We  are  currently  investigating  whether 
TAN-1 can interact with several other R.el/NF-KB proteins 
and  whether  these  alterations  in  p50  complexes  can  be 
consistently  detected  in  these  tumors.  Inappropriately  ex- 
pressed human TAN-1 may contribute to tumorigenesis by 
regulating NF-KB gene expression  (as seen for the  c-Rel, 
p50B,  and Bcl-3 genes) particularly when  Notch has been 
affected by chromosomal translocation. 
The function of Notch/TAN-1  as a regulator of NF-KB 
provides  a preliminary  understanding  of its  importance  in 
human development, immunology, and oncogenesis. 
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